We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Use of Glucose and Saline for Fetal Movement Perception

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01308359
Recruitment Status : Unknown
Verified March 2011 by Tel-Aviv Sourasky Medical Center.
Recruitment status was:  Recruiting
First Posted : March 4, 2011
Last Update Posted : March 4, 2011
Information provided by:
Tel-Aviv Sourasky Medical Center

Brief Summary:
The purpose of this study is to investigate the hypothesis that glucose administration increases fetal movement perception by the pregnant woman.

Condition or disease Intervention/treatment
Fetal Movement Perception Drug: IV glucose 5% Drug: saline

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Impact of Glucose Administration on Perception of Fetal Movements
Study Start Date : January 2011
Estimated Primary Completion Date : January 2012
Estimated Study Completion Date : January 2012

Resource links provided by the National Library of Medicine

Drug Information available for: Dextrose
U.S. FDA Resources

Arm Intervention/treatment
Experimental: glucose 5%
glucose 5%
Drug: IV glucose 5%
500 ml glucose 5% within 30 minutes
Active Comparator: saline
Drug: saline

Primary Outcome Measures :
  1. fetal movements as perceived by the mother [ Time Frame: one hour ]
    Effect of glucose versus saline infusion on the perception of fetal movements. the mother will count fetal movements that she feels one hour following saline/glucose infusion and report to the obstetrician in charge. The research aims to clarify whether glucose increases fetal movements.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Healthy parturients with singleton pregnancy during 3rd trimester

Exclusion Criteria:

  • Any maternal medical condition (Diabetes, hypertension), multiple pregnancy, fetal anomaly, polyhydramnios

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01308359

Contact: Ariel Many, MD 97236925633 many@post.tau.ac.il
Contact: NAdav Mishan, MD 97236925633 nadavmi@gmail.com

Lis Maternity Hospital, Tel Aviv Sourasky Medical Center Recruiting
Tel Aviv, Israel, 64239
Contact: Ariel Many, MD    97236925633      
Contact: Nadav Mishan, MD    97236925633      
Principal Investigator: Ariel Many, MD         
Sub-Investigator: Nadav Mishan, MD         
Sponsors and Collaborators
Tel-Aviv Sourasky Medical Center
Principal Investigator: Ariel Many, MD Lis Maternity Hospital

Responsible Party: Ariel Many, MD, Dep. of OB&GYN, Tel Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier: NCT01308359     History of Changes
Other Study ID Numbers: TASMC-10-am-0512-CTIL
First Posted: March 4, 2011    Key Record Dates
Last Update Posted: March 4, 2011
Last Verified: March 2011

Keywords provided by Tel-Aviv Sourasky Medical Center:
fetal movement